کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
1931272 | 1050547 | 2011 | 6 صفحه PDF | دانلود رایگان |
This study examined the role of AMPK activation in osteoblast differentiation and the underlining mechanism. An AMPK activator (AICAR or metformin) stimulated osteoblast differentiation with increases in ALP and OC protein production as well as the induction of AMPK phosphorylation in MC3T3E1 cells. In addition, metformin induced the phosphorylation of Smad1/5/8 and expression of Dlx5 and Runx2, whereas compound C or dominant negative AMPK inhibited these effects. Transient transfection studies also showed that metformin increased the BRE-Luc and Runx2-Luc activities, which were inhibited by DN-AMPK or compound C. Down-regulation of Dlx5 expression by siRNA suppressed metformin-induced Runx2 expression. These results suggest that the activation of AMPK stimulates osteoblast differentiation via the regulation of Smad1/5/8-Dlx5-Runx2 signaling pathway.
Research highlights
► Meformin or AICAR increases AMPK activation in osteoblast cells.
► AMPK increases Smad1/5/8 phosphorylation.
► AMPK increases Runx2 expression via Smad1/5/8-Dlx5 signaling pathway.
► Metformin positively regulates osteoblast differentiation through AMPK-dependent Runx2 expression.
Journal: Biochemical and Biophysical Research Communications - Volume 404, Issue 4, 28 January 2011, Pages 1004–1009